CLINICAL_TRIALS
trial_result
· 2013-08-08
Clinical Trial Update: Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Summary
Pfizer completed and posted results of a postmarketing drug-use investigation for Voriconazole (Vfend) related to systemic mycosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Systemic Mycosis | Status: COMPLETED | Results posted: 2013-08-08